CSL Behring Scoops Up This U.S. Biotech for $416 Million Post author:Sam Post published:August 27, 2017 Post category:BioPharma August 28, 2017By Mark Terry, BioSpace.com Breaking News StaffMelbourne, Australia… Source: BioSpace You Might Also Like <b>Genetic Technologies</b> Announces Comprehensive Review Of Strategic Alternatives August 27, 2017 Booming Visterra Outgrows Kendall Square Space, Heads to Suburbs February 5, 2018 Gilead Announces 144-Week Data Evaluating Safety And Efficacy Of Genvoya For Treatment Of HIV-1 In Treatment-Na??ve Adults February 14, 2017
Gilead Announces 144-Week Data Evaluating Safety And Efficacy Of Genvoya For Treatment Of HIV-1 In Treatment-Na??ve Adults February 14, 2017
